ABCB1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 | Cancer-related genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
AC009060.1 | Uncharacterized protein | | | | | | Tissue enhanced |
AC115618.1 | Uncharacterized protein; cDNA FLJ26048 fis, clone PRS02384 | | | | | | Tissue enhanced |
AC120194.1 | | Predicted membrane proteins
| | | | | Tissue enhanced |
ADAMTSL2 | ADAMTS-like 2 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AGRP | Agouti related protein homolog (mouse) | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AMHR2 | Anti-Mullerian hormone receptor, type II | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
ANO4 | Anoctamin 4 | Predicted membrane proteins
| | | | | Tissue enhanced |
AOX1 | Aldehyde oxidase 1 | Enzymes Plasma proteins
| | | | | Tissue enhanced |
AP000350.10 | Uncharacterized protein | Predicted membrane proteins
| | | | | Tissue enhanced |
AP001579.1 | Uncharacterized protein | | | | | | Tissue enhanced |
ARC | Activity-regulated cytoskeleton-associated protein | | | | | | Tissue enhanced |
ASTN1 | Astrotactin 1 | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
AVPR1A | Arginine vasopressin receptor 1A | FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
C19orf26 | Chromosome 19 open reading frame 26 | Predicted membrane proteins
| | | | | Tissue enhanced |
C1QTNF1-AS1 | C1QTNF1 antisense RNA 1 | | | | | | Tissue enhanced |
C2orf66 | Chromosome 2 open reading frame 66 | Predicted secreted proteins
| | | | | Tissue enhanced |
C7 | Complement component 7 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
C9orf47 | Chromosome 9 open reading frame 47 | Predicted secreted proteins
| | | | | Tissue enhanced |
CABP7 | Calcium binding protein 7 | Predicted membrane proteins
| | | | | Tissue enhanced |
CALN1 | Calneuron 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
CBLN4 | Cerebellin 4 precursor | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CHGA | Chromogranin A (parathyroid secretory protein 1) | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CNGB1 | Cyclic nucleotide gated channel beta 1 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
COL22A1 | Collagen, type XXII, alpha 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
CTC-360G5.8 | Serine--tRNA ligase, mitochondrial | | | | | | Tissue enhanced |
CYP2W1 | Cytochrome P450, family 2, subfamily W, polypeptide 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
DFNB31 | Deafness, autosomal recessive 31 | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
DNAH11 | Dynein, axonemal, heavy chain 11 | Disease related genes
| | | | | Tissue enhanced |
DNAJC12 | DnaJ (Hsp40) homolog, subfamily C, member 12 | | | | | | Tissue enhanced |
DPP10 | Dipeptidyl-peptidase 10 (non-functional) | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
DRD2 | Dopamine receptor D2 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
EPHA8 | EPH receptor A8 | Cancer-related genes Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
EVX1 | Even-skipped homeobox 1 | Transcription factors
| | | | | Tissue enhanced |
FAM150B | Family with sequence similarity 150, member B | Predicted secreted proteins
| | | | | Tissue enhanced |
FAM163A | Family with sequence similarity 163, member A | Predicted membrane proteins
| | | | | Tissue enhanced |
FGF11 | Fibroblast growth factor 11 | RAS pathway related proteins
| | | | | Tissue enhanced |
FIBCD1 | Fibrinogen C domain containing 1 | | | | | | Tissue enhanced |
FNDC4 | Fibronectin type III domain containing 4 | Predicted membrane proteins
| | | | | Tissue enhanced |
GABRQ | Gamma-aminobutyric acid (GABA) A receptor, theta | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
GALR1 | Galanin receptor 1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GHRHR | Growth hormone releasing hormone receptor | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
GJD2 | Gap junction protein, delta 2, 36kDa | Predicted membrane proteins
| | | | | Tissue enhanced |
GNG8 | Guanine nucleotide binding protein (G protein), gamma 8 | RAS pathway related proteins
| | | | | Tissue enhanced |
GPR123 | G protein-coupled receptor 123 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GRAMD1B | GRAM domain containing 1B | Predicted membrane proteins
| | | | | Tissue enhanced |
GSTA3 | Glutathione S-transferase alpha 3 | Enzymes
| | | | | Tissue enhanced |
GSTT2 | Glutathione S-transferase theta 2 | Enzymes
| | | | | Tissue enhanced |
GSTT2B | Glutathione S-transferase theta 2B (gene/pseudogene) | Enzymes
| | | | | Tissue enhanced |
HOXA5 | Homeobox A5 | Cancer-related genes Transcription factors
| | | | | Tissue enhanced |